MIFH
CLBT icon

Migdal Insurance & Financial Holdings’s Cellebrite CLBT Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,350,000
Closed -$24.3M – 367
2025
Q4 		$24.3M Buy
1,350,000
+300,000
+29% +$5.39M 0.21% 60
2025
Q3 		$19.5M Buy
+1,050,000
New +$16.5M 0.21% 63
2022
Q2 		– Sell
-1,400,000
Closed -$8.96M – 613
2022
Q1 		$8.96M Hold
1,400,000
– – 0.16% 88
2021
Q4 		$11.2M Hold
1,400,000
– – 0.11% 110
2021
Q3 		$13M Buy
+1,400,000
New +$14.6M 0.14% 104

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CLBT Position: Q1 2026 in Review

Migdal Insurance & Financial Holdings sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 1,350,000 shares — an estimated $24.3M sold.

Migdal Insurance & Financial Holdings first reported a position in CLBT in Q3 2021 and held it in 5 quarters. The position peaked at $24.3M in Q4 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Migdal Insurance & Financial Holdings reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1,350,000 Cellebrite shares in Q1 2026, an estimated $24.3M.
  • Migdal Insurance & Financial Holdings first reported a position in Cellebrite in Q3 2021 and held it in 5 quarters.
  • Migdal Insurance & Financial Holdings's Cellebrite position peaked at $24.3M in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2026, filed 14 May 2026.